Here we demonstrate that combination treatment of cytochrome b inhibitors and a low dose of BNZ, the current first-line treatment (49), results in full efficacy in our mouse model of chronic Chagas disease in a short five-day treatment regimen. Here, MT-CYB is linked to Chagas disease.